BCL2A1 and B-cell chronic lymphocytic leukemia: Inhibition of constitutive and inducible NF-κB using NF-κB inhibitors induced apoptosis and enhances fludarabine effects on B-CLL associated with downregulation of bfl-1 and other antiapoptotic genes (Horie et al, 2006).